These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 31609999

  • 1. Kawasaki Disease: Beyond IVIG and Aspirin.
    Moussa T, Wagner-Weiner L.
    Pediatr Ann; 2019 Oct 01; 48(10):e400-e405. PubMed ID: 31609999
    [Abstract] [Full Text] [Related]

  • 2. Incomplete Kawaski disease: are we missing it?
    Billoo AG, Lone SW, Siddiqui S, Atiq H.
    J Pak Med Assoc; 2009 Jan 01; 59(1):42-3. PubMed ID: 19213377
    [Abstract] [Full Text] [Related]

  • 3. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Jan 01; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 4. Recurrent Kawasaki disease.
    Balasubramanian S, Ganesh R.
    Indian J Pediatr; 2009 Aug 01; 76(8):848-9. PubMed ID: 19475343
    [Abstract] [Full Text] [Related]

  • 5. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P.
    Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Pediatrics; 2004 Dec 26; 114(6):1708-33. PubMed ID: 15574639
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics.
    Circulation; 2004 Oct 26; 110(17):2747-71. PubMed ID: 15505111
    [Abstract] [Full Text] [Related]

  • 8. Kawasaki disease.
    Scuccimarri R.
    Pediatr Clin North Am; 2012 Apr 26; 59(2):425-45. PubMed ID: 22560578
    [Abstract] [Full Text] [Related]

  • 9. The diagnosis and management of Kawasaki disease.
    Royle J, Burgner D, Curtis N.
    J Paediatr Child Health; 2005 Mar 26; 41(3):87-93. PubMed ID: 15790316
    [Abstract] [Full Text] [Related]

  • 10. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM, Shulman ST.
    J Clin Pharm Ther; 2015 Dec 26; 40(6):620-5. PubMed ID: 26547265
    [Abstract] [Full Text] [Related]

  • 11. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
    Williams K.
    J Pediatr Health Care; 2017 Dec 26; 31(2):196-202. PubMed ID: 27592169
    [Abstract] [Full Text] [Related]

  • 12. Myocarditis and Kawasaki disease.
    Dionne A, Dahdah N.
    Int J Rheum Dis; 2018 Jan 26; 21(1):45-49. PubMed ID: 29105303
    [Abstract] [Full Text] [Related]

  • 13. [Kawasaki disease].
    Cimaz R, Lega JC.
    Rev Prat; 2007 Nov 30; 57(18):1985-8. PubMed ID: 18326430
    [Abstract] [Full Text] [Related]

  • 14. A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.
    Kossiva L, Karanassios E, Papadopoulos G, Karavanaki K.
    Cardiol Young; 2012 Aug 30; 22(4):461-5. PubMed ID: 21933460
    [Abstract] [Full Text] [Related]

  • 15. Complete Kawasaki disease (KD) with peculiar skin manifestations.
    Poddighe D.
    BMJ Case Rep; 2017 Oct 09; 2017():. PubMed ID: 28993368
    [No Abstract] [Full Text] [Related]

  • 16. Acute gastrointestinal hemorrhage in Kawasaki disease occurring before aspirin therapy.
    Asada D, Taura Y, Itoh H, Tatsumi Y.
    Pediatr Int; 2019 Nov 09; 61(11):1177-1178. PubMed ID: 31773846
    [No Abstract] [Full Text] [Related]

  • 17. Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
    Pilania RK, Jindal AK, Johnson N, Prithvi A, Vignesh P, Suri D, Rawat A, Gupta A, Singh S.
    Rheumatology (Oxford); 2021 Jul 01; 60(7):3413-3419. PubMed ID: 33221920
    [Abstract] [Full Text] [Related]

  • 18. Acute cholestasis: atypical onset of Kawasaki disease.
    Valentini P, Ausili E, Schiavino A, Angelone DF, Focarelli B, De Rosa G, Ranno O.
    Dig Liver Dis; 2008 Jul 01; 40(7):582-4. PubMed ID: 18055284
    [Abstract] [Full Text] [Related]

  • 19. Kawasaki disease: diagnosis, management, and long-term implications.
    Satou GM, Giamelli J, Gewitz MH.
    Cardiol Rev; 2007 Jul 01; 15(4):163-9. PubMed ID: 17575479
    [Abstract] [Full Text] [Related]

  • 20. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
    De Rosa G, Pardeo M, Rigante D.
    Eur Rev Med Pharmacol Sci; 2007 Jul 01; 11(5):301-8. PubMed ID: 18074939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.